1. Home
  2. AZTR vs LCFY Comparison

AZTR vs LCFY Comparison

Compare AZTR & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • LCFY
  • Stock Information
  • Founded
  • AZTR 2014
  • LCFY 2009
  • Country
  • AZTR United States
  • LCFY Australia
  • Employees
  • AZTR N/A
  • LCFY N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • LCFY
  • Sector
  • AZTR Health Care
  • LCFY
  • Exchange
  • AZTR Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • AZTR 5.2M
  • LCFY 5.8M
  • IPO Year
  • AZTR 2023
  • LCFY 2022
  • Fundamental
  • Price
  • AZTR $0.28
  • LCFY $3.98
  • Analyst Decision
  • AZTR
  • LCFY
  • Analyst Count
  • AZTR 0
  • LCFY 0
  • Target Price
  • AZTR N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • AZTR 806.0K
  • LCFY 12.9K
  • Earning Date
  • AZTR 05-13-2025
  • LCFY 06-17-2025
  • Dividend Yield
  • AZTR N/A
  • LCFY N/A
  • EPS Growth
  • AZTR N/A
  • LCFY N/A
  • EPS
  • AZTR N/A
  • LCFY N/A
  • Revenue
  • AZTR $7,500.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • AZTR N/A
  • LCFY N/A
  • Revenue Next Year
  • AZTR N/A
  • LCFY N/A
  • P/E Ratio
  • AZTR N/A
  • LCFY N/A
  • Revenue Growth
  • AZTR N/A
  • LCFY N/A
  • 52 Week Low
  • AZTR $0.23
  • LCFY $2.20
  • 52 Week High
  • AZTR $12.00
  • LCFY $11.23
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 44.09
  • LCFY 43.83
  • Support Level
  • AZTR $0.27
  • LCFY $3.86
  • Resistance Level
  • AZTR $0.29
  • LCFY $4.30
  • Average True Range (ATR)
  • AZTR 0.02
  • LCFY 0.21
  • MACD
  • AZTR -0.00
  • LCFY -0.02
  • Stochastic Oscillator
  • AZTR 30.20
  • LCFY 19.78

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: